Co-Authors
This is a "connection" page, showing publications co-authored by XIAOPING SU and FUNDA MERIC-BERNSTAM.
Connection Strength
1.070
-
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancer Res. 2021 11 01; 81(21):5572-5581.
Score: 0.200
-
Correction: FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells. Oncotarget. 2019 Dec 10; 10(65):7014-7015.
Score: 0.177
-
FGFR1? is a driver isoform of FGFR1 alternative splicing in breast cancer cells. Oncotarget. 2019 Jan 01; 10(1):30-44.
Score: 0.166
-
Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes. Oncotarget. 2014 Oct 30; 5(20):9864-76.
Score: 0.124
-
Concordance of genomic alterations between primary and recurrent breast cancer. Mol Cancer Ther. 2014 May; 13(5):1382-9.
Score: 0.119
-
Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol. 2013 Aug; 87(16):8916-26.
Score: 0.113
-
PurityEst: estimating purity of human tumor samples using next-generation sequencing data. Bioinformatics. 2012 Sep 01; 28(17):2265-6.
Score: 0.106
-
Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel. Oncotarget. 2016 Nov 01; 7(44):71686-71695.
Score: 0.036
-
PD-L1 expression in triple-negative breast cancer. Cancer Immunol Res. 2014 Apr; 2(4):361-70.
Score: 0.029